| | |||||
| disease | |||||
| 新闻 | |||||
| Communicable disease threats report, 30 January - 5 February 2023, week 5 - ECDC This issue of the Communicable Disease Threats Report (CDTR) covers the period 30 January - 5 February 2023 and includes updates on COVID-19, ...
| |||||
| Heart Disease Breakthrough: New Immune Target Discovered - SciTechDaily Research has identified suPAR as a protein that contributes to the development of atherosclerosis and kidney disease, offering new opportunities ...
| |||||
| MHRA approves first oral advanced therapy for Crohn's disease "We are pleased that upadacitinib can now be used to treat more people with inflammatory bowel disease," commented Belinda Byrne, Medical Director, ...
| |||||
| Researchers map brain cell changes in Alzheimer's disease | MIT News A common sign of Alzheimer's disease is the excessive buildup of two types of protein in the brain: tangles of tau proteins that accumulate inside ...
| |||||
| Could vitamins help you avoid diabetes, heart disease? Here's what a Texas State researcher found Could vitamins like B6, B12 and folate be a key to reducing the risk of heart disease and diabetes? Dr. Jie Zhu, an assistant professor at Texas ...
| |||||
| Jury awards 25-year-old's parents $6.5 million for Lyme disease misdiagnosis Henson at Mercy Hospital, which is owned by Northern Light Health of Brewer, but was not diagnosed with Lyme disease, according to the family's legal ...
| |||||
| |||||
| Study provides an explanation and potential solution for severe graft-versus-host disease The severity of immune-mediated intestinal diseases such as graft-versus-host disease (GVHD) or inflammatory bowel diseases is known to be ...
| |||||
| FDA Approves Daprodustat for Anemia From Chronic Kidney Disease in Adult Dialysis Patients The FDA has approved daprodustat (Jesduvroq, GSK) for the once daily treatment of anemia caused by chronic kidney disease (CKD) in adults ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment